"Mind the gap" - The Impact of variations in the duration of the treatment gap and overall treatment time in the first UK anal cancer trial (ACT I)

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 5, 2011, Pages 1488-1494

  Glynne Jones, Rob ^a   Sebag Montefiore, David ^b   Adams, Richard ^c   McDonald, Alec ^d   Gollins, Simon ^e   James, Roger ^f   Northover, John M A ^g   Meadows, Helen M ^h   Jitlal, Mark ^h  

^a MOUNT VERNON CANCER CENTRE   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

^e GLAN CLWYD HOSPITAL   (United Kingdom)

^f MAIDSTONE HOSPITAL   (United Kingdom)

^g ST MARK S HOSPITAL   (United Kingdom)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Chemoradiation; Locoregional control; Overall treatment time; Squamous cell carcinoma of the anus; Treatment gaps

Indexed keywords

CHEMORADIATION; LOCOREGIONAL CONTROL; OVERALL TREATMENT TIME; SQUAMOUS CELL CARCINOMA OF THE ANUS; TREATMENT GAPS;

IRIDIUM; RADIOTHERAPY;

DISEASES;

FLUOROURACIL; IRIDIUM 192; MITOMYCIN C;

ANUS CANCER; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER THERAPY; CLINICAL PROTOCOL; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DOSE REDUCTION; EXTERNAL BEAM RADIOTHERAPY; HAZARD RATIO; HUMAN; IMPLANT; LONG TERM CARE; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION NECROSIS; RECOMMENDED DRUG DOSE; RETROSPECTIVE STUDY; RISK REDUCTION; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; UNITED KINGDOM;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CONTINUITY OF PATIENT CARE; DOSE FRACTIONATION; FLUOROURACIL; GREAT BRITAIN; HUMANS; IRIDIUM RADIOISOTOPES; MITOMYCIN; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 81855192753     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.07.1995     Document Type: Article

References (48)

1. H. Bartelink, F. Roelofsen, and F. Eschwege Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European organization for research and treatment of cancer radiotherapy and gastrointestinal cooperative groups J Clin Oncol 15 1997 2040 2049 (Pubitemid 27209535)
2. M. Flam, M. John, and T.F. Pajak Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study J Clin Oncol 14 1996 2527 2539 (Pubitemid 26300120)
3. UKCCCR Anal Cancer Working Party Epidermoid anal cancer: results from the UKCCCR randomized trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin Lancet 348 1996 1049 1054
4. J.A. Ajani, K.A. Winter, and L.L. Gunderson Fluorouracil, mitomycin and radiotherapy vs fluorouracil, cisplatin and radiotherapy for carcinoma of the anal canal: A randomized controlled trial JAMA 199 2008 1914 1921 (Pubitemid 351574921)
5. B.J. Cummings, T.J. Keane, and B. O'Sullivan Epidermoid anal cancer: Treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C Int J Radiat Oncol Biol Phys 21 1991 1115 1125
6. B.J. Cummings Anal cancer-radiation alone or with cytotoxic drugs? Int J Radiat Oncol Biol Phys 27 1993 173 175 (Pubitemid 23270672)
7. T.A. Rich, J.A. Ajani, and W.H. Morrison Chemoradiation therapy for anal cancer: Radiation plus continuous infusion of 5-fluorouracil with or without cisplatin Radiother Oncol 27 1993 209 215 (Pubitemid 23270046)
8. J.A. Martenson, S.R. Lipsitz, and H. Wagner Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292) Int J Radiat Oncol Biol Phys 35 1996 745 749 (Pubitemid 26251129)
9. B. Friberg, C. Svensson, and S. Goldman Induction chemotherapy and radiotherapy in loco-regionally advanced epidermoid carcinoma of the anal canal Int J Radiat Oncol Biol Phys 41 1998 863 867 (Pubitemid 28285966)
10. B. Cummings, T. Keane, and G. Thomas Results and toxicity of the treatment of anal canal carcinoma by radiation therapy or radiation therapy and chemotherapy Cancer 54 1984 2062 2068 (Pubitemid 15210787)
11. B.J. Cummings Current Management of anal canal cancer Semin Oncol 32 Suppl. 9 2005 S123 S128
12. F. Eschwege, P. Lasser, and A. Chavy Squamous cell carcinoma of the anal canal: treatment by external beam radiation Radiother Oncol 4 1985 145 150 (Pubitemid 15170209)
13. M. Schlienger, C. Krzisch, and F. Pene Epidermoid carcinoma of the anal canal treatment results and prognostic variables Int J Radiat Oncol Biol Phys 17 1989 1141 1151 (Pubitemid 20028629)
14. R.J. Salmon, J. Fenton, and B. Asselain Treatment of epidermoid anal cancer Am J Surg 147 1984 43 48
15. E. Touboul, M. Schlienger, and L. Buffat Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients Cancer 73 1994 1569 1579 (Pubitemid 24085255)
16. G. Tanum, K. Tveit, and K.O. Karlsen Chemotherapy and radiation therapy for anal carcinoma. Survival and late morbidity Cancer 67 1991 2462 2466
17. J. Papillon, and J.F. Montbarbon Epidermoid carcinoma of the anal canal: A series of 276 cases Dis Colon Rectum 30 1987 324 333 (Pubitemid 17078513)
18. D.C. Weber, J. Kurtz, and A.S. Allal Impact duration of local control in anal canal carcinoma treated by split course radiotherapy and concomitant chemotherapy Int J Radiat Oncol Biol Phys 50 2001 675 680 (Pubitemid 32519596)
19. E. Deniaoud-Alexandre, E. Touboul, and E. Tiret Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal Int J Radiat Oncol Biol Phys 56 2003 1259 1273 (Pubitemid 36842877)
20. B.J. Cummings, and J.D. Brierley Anal canal C.A. Perez, L.W. Brady, E.C. Halperin, Principles and practice of radiation oncology 4th ed 2003 Lippincott, Williams and Wilkins Philadelphia 1630 1648
21. A. Meyer, J. Meier Zu Eissen, and J.H. Karstens Chemotherapy in patients with anal cancer: Impact of length of unplanned treatment interruption on outcome Acta Oncol 45 2006 728 735
22. A. Konski, M. Garcia, and M. John Evaluation of planned treatment breaks during radiation therapy for anal cancer: Update of RTOG 92-08 Int J Radiat Oncol Biol Phys 72 2008 114 118
23. G.L. Cerisoli, A.J. Ferriri, and S. Cordio Role of dose intensity and conservative treatment of anal canal carcinoma; Report of 35 cases Oncology 55 1998 525 532 (Pubitemid 28479110)
24. R. Graf, P. Wust, and B. Hilderbrant Impact of overall treatment time on local control of anal cancer treated with radiochemotherapy Oncology 65 2003 14 22 (Pubitemid 36829086)
25. J.F. Bosset, F. Roelofsen, and D.A.L. Morgan Shortened irradiation schedule, continuous infusion of 5-fluorouracil and fractionation of mitomycin C in locally advanced anal carcinomas. Results of a phase II study of the European Organization for Research and Treatment of Cancer. Radiotherapy and Gastrointestinal Cooperative Groups Eur J Cancer 39 2003 45 51 (Pubitemid 36005424)
26. G. Crehange, M. Bosset, and F. Lorchel Combining cisplatin and mitomycin with radiotherapy in anal carcinoma Dis Colon Rectum 50 2006 43 49 (Pubitemid 46147020)
27. O. Matzinger, F. Roelofsen, L. Mineur For the EORTC Radiation Oncology and Gastrointestinal Tract Cancer Groups Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014) Eur J Cancer 45 2009 2782 2791
28. A. Melcher, and D. Sebag-Montefiore Concurrent chemoradiotherapy for squamous cell carcinoma of the anus using a shrinking field technique with no boost B J Cancer 83 2003 1352 1357 (Pubitemid 36606414)
29. M. Osborne, R. Glynne-Jones, and A. Makris Chemoradiation followed by immediate boost in squamous cell carcinoma of the anus B J Cancer 83 Suppl 1 2000 Abstract P71p46
30. R. James, H. Meadows, and S. Wan ACT II: The second UK phase III anal cancer trial Clin Oncol 17 2005 364 366 (Pubitemid 40932110)
31. B. Spiessl, P. Hermanek, and O. Scheibe UICC TNM-Atlas Illustrated Guide to the TNM/pTNM-Classification of Malignant Tumours 2nd ed 1985 Springer-Verlag Berlin
32. J.F. Fowler, and M.J. Lindstrom Loss of local control with prolongation in radiotherapy Int J Radiat Oncol Biol Phys 23 1992 457 467
33. S.M. Bentzen Repopulation in radiation oncology: Perspectives of clinical research Int J Radiat Biol 79 2003 581 585 (Pubitemid 37311064)
34. J.J. Kim, and I.F. Tannock Repopulation of cancer cells during therapy: An important cause of treatment failure Nat Rev Cancer 5 2005 516 525 (Pubitemid 40942828)
35. B. Maciejewski, G. Preuss-Bayer, and K.R. Trott The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx Int J Radiat Oncol Biol Phys 9 1983 321 328 (Pubitemid 13055174)
36. K. Skladowski, M.G. Law, and B. Maciejewski Planned and unplanned gaps in radiotherapy: The importance of gap position and gap duration Radiother Oncol 30 1994 109 120 (Pubitemid 24101568)
37. J.H. Hendry, S.M. Bentzen, and R.G. Dale A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy Clin Oncol (R Coll Radiol) 8 1996 297 307 (Pubitemid 26382026)
38. E.C. Constantinou, W. Daly, and C.Y. Fung Time-dose considerations in the treatment of anal cancer Int J Radiat Oncol Biol Phys 39 1997 651 657 (Pubitemid 27441432)
39. R.W. Tsang, C.S. Wong, and A.W. Fyles Tumour proliferation and apoptosis in human uterine cervix carcinoma II: Correlations with clinical outcome Radiother Oncol 50 1999 93 101 (Pubitemid 29136743)
40. E. Ben-Josef, J. Moughan, and J. Ajani The impact of overall treatment time on survival and local control in anal cancer patients: A pooled data analysis of RTOG trials 8704and 9811 Int J Radiat Oncol Biol Phys 75 Suppl. ASTRO 2009 S26 [abstract 55]
41. N.A. Scott, R.W. Bearht Jr., and L.H. Weiland Carcinoma of the anal canal and flow cytometric DNA analysis Br J Cancer 60 1989 56 58 (Pubitemid 19187746)
42. C.S. Wong, R.W. Tsang, and B.J. Cummings Proliferation parameters in epidermoid carcinomas of the anal canal Radiother Oncol 56 2000 349 353
43. M. John, T. Pajak, and M. Flam Dose escalation in chemoradiation for anal cancer: Preliminary results of RTOG 92-08 Cancer J Sci Am 2 1996 205 211
44. Matthews, John on behalf of TROG 99.02 participants Early anal canal carcinoma-the Trans-Tasman Radiation Oncology Group (TROG) experience in TROG 99.02 study Aust Radiol 49 2005 A3
45. D. Peiffert, P. Bey, and M. Pernot Conservative treatment by irradiation of epidermoid cancers of the anal canal: Prognostic factors of tumoral control and complications Int J Radiat Oncol Biol Phys 37 1997 313 324 (Pubitemid 27138714)
46. R. James, S. Wan, and R. Glynne-Jones A randomized trial of chemoradiation using combination 5FU/mitomycin or 5FU/cisplatin, with or without maintenance cisplatin/5FU in squamous cell carcinoma of the anus (ACT II) J Clin Oncol Suppl.15 2009 27 [abstract LBA4009]:170s
47. L. Kachnic, K. Winter, and R. Myerson RTOG 0529: A phase II evaluation of dose painted IMRT in combination with 5-fluorouracil and mitomycin C for reduction of acute morbidity in carcinoma of the anal canal Int J Radiat Oncol Biol Phys 75 Suppl. ASTRO 2009 S5 [abstract 10]
48. N.D. Nigro, H.G. Seydel, and B. Considine Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal Cancer 51 1983 1826 1829 (Pubitemid 13093950)